Melanoma Risk with PDE5 Inhibitors Likely Due to Sun, Not Side Effect
The small apparent increase in risk of melanoma in men prescribed phosphodiesterase type 5 (PDE5) inhibitors may be explained by greater sun exposure, according to new research published online in PLOS Medicine.